Category Archives: Cancer

Tempus Labs And Co-Founder Eric Lefkofsky Work Together To Help Treat Cancer

Located in Chicago, Illinois is Tempus Labs, a technology cancer research center that gathers molecular data to find similarities in previous cancer patients treatment plans to those currently undergoing treatment plans and for those in the future to find the right treatment plans. Tempus Labs is Co-founded Eric Lefkofsky who is known for his work with Groupon and many other companies over his career.

Tempus Labs was founded a little longer than two years ago and has been thriving ever since startup. To date, Tempus Labs has raised over 210 million dollars towards their research for cancer treatment data. Tempus makes it their mission to provide patients and their families with peace of mind, care, and comfort when using Tempus Labs. Tempus Labs has the technology to look closely at a patients tumor and decide based on the way the tumor looks, is growing, and the molecular data gathered in the past by any similar previous patients what treatment options might be best for their patients. Then they use this information to not only find a cancer treatment plan for their patients but they also discuss the treatment plan with the patient’s doctor.

Tempus Labs works closely with many cancer research centers as well as in the area doctors who specialize in cancer treatment who are looking for more innovative ways to figure out what is best for their patients when it comes to treatment. With more than 4,000 employees Tempus Labs is able to always be there for patients when they need somebody to talk to about their cancer treatment plan.

Together alongside modern doctors the modern technology Tempus is provided with to find data they can change the world into a better place and make it easier to rid patients of the terrible illness of cancer with the right treatment options. Tempus Continues to serve cancer patients all over the Chicagoland area. Although they are located in Chicago many patients from all over the united states come to find treatment with Tempus that might help them overcome their battle with cancer faster or even easier/ with a smarter approach.

To Read More Click Here

Eric Lefkofsky Tempus Unicorn Funding

Eric Lefkofsky, a philanthropist, co-founder and the Chief Executive Officer of Tempus Unicorn health company founded in the year 2015. The organization focuses on treating cancer using modern technology on a large volume of clinical and molecular data for analysis. Tempus is among the most substantial cancer database firm across the globe fighting against the chronic cancer disease. Lefkofsky is not only an entrepreneur but also a prominent investor who has helped the organization in achieving its goals.

Tempus has exponentially grown in providing health care services through the building of operating system used to treat cancer. The objective is to redefine the use of genomic data in the clinical procedures. Doctors consider treatment of the patients attended after the accumulation of the collected data to be advantageous because the physician gets equipped with appropriate tools from the received data.

The company has continuously received financial support from the investors to help Tempus in attaining its goals through medical equipment and modern facilities. The Chief Executive Officer, Lefkofsky on 20th March 2018 stated through Chicago business magazine that the company had received additional funds amounting to $80 million from new and existing investors. Investors initiated an agenda of caring and minimizing the number of cancer patients. These organizations include New Enterprise Associates, Revolution Growth, and New Investors Trust Co.

In approximately two years since the establishment of the company, it has received about $210 million from sponsors. New Enterprise Associates have majorly invested in Unicorn Company co-founded by Eric Lefkofsky. During the latest funds, a business partner, Brad Keywell, and Revolution Ventures founder, Steve Case financed along with the Tempus CEO.

Despite being founded out of health care system frustrations, Tempus wasted real-world evidence important data that was essential in cancer therapy. But later on, Unicorn picked up as a result of the advanced technology. Medicine precision is currently used to support cancer patients.

Tempus Unicorn uses clinical data as a way of learning trends in molecular data collection and treatment of cancer patients under diagnosis. The interest of the CEO to partner with other organizations has created a pathway of attaining its mission through sequencing, bioinformatics and machine learning.

To Know More Click Here

Dr. Samadi gives cancer treatment a new boost with his SMART technique

Prostate cancer is one of the worst nightmares that a man can ever face. It eats into a man’s health, ego and finally takes away his life. Dr. David Samadi understands the pain that cancer patients go through. It is for this reason that he has dedicated his life and career studying the newest techniques to treat prostate cancer. If you have prostate cancer and you are in New York, then Dr. David Samadi is the man you should book an appointment with soonest possible. It is not just because he is a qualified urologist, but because he has spent the last three decades studying prostate cancer. He invented a new surgical procedure known as SMART technique that drastically reduced the time a patient takes to heal. It also decreased the damaged that results from prostate surgery. Thus, patients can recover faster and retain their sexual health.

Education background

Dr. Samadi is one of the most educated and experienced urologists in the U.S. He was born and raised in an Iranian Jewish community. In 1979, they ran away from their country during the Iranian revolution. Samadi, together with his brother made their way to Belgium. They were separated from the rest of the family while very young.
Dr. David Samadi studied in both Belgium and London. Samadi then moved to the U.S where he completed his high school studies under full scholarship. Dr. Samadi had a taste for education. After high school, he enrolled at various universities where he earned his bachelor’s degree in biochemistry, and master’s degree in oncology and urology. Samadi then went on to do his fellowship in oncology, urology, and general surgery. Dr. Samadi is one of the few highly trained oncologic surgeons in the United States having specialized in laparoscopic surgery open and robotic minimally invasive surgery.

SMART Surgery technique

Dr. Samadi utilizes SMART Technique, a new surgical procedure that he established a few years ago. It utilizes some of the most modern equipment to remove cancer cells. This technique has been subject to intense research. It has been established that SMART technique is more effective than the traditional prostate surgical procedures.

Dr. Samadi’s awards

Dr. Samadi has won many awards over the years for his contributions in the field of oncology. Some of the notable awards include the Best Urologist in New York, America’s Top Doctors For Cancer, Patient’s Choice Award, Americas Top Doctors and many more.

Dr. Samadi has embraced the modern technology, and as a result, he runs social media pages such as Facebook, Twitter, and Instagram where he engages with his followers.

Learn More: prostatecancer911.com/david-samadi/

Eric Lefkofsky And The Work At Tempus

Mr. Eric Lefkofsky is widely known for his work at one of his most recent creations. The company Tempus is working in tech development and has recently started contributing significantly to medical research and biotech. Mr. Erik Lefkofsky is working as the leader of the business.

In addition to his roles in Tempus, Mr. Eric Lefkofsky also holds the title as co-founder and Chairman of Groupon, an American global e-commerce marketplace. Over the course of his career in business, he has established and co-founded a number of businesses in a variety of industries. Most of the companies, however, are working in the tech industry as well as in the telecommunication business.

For the past few years, Mr. Eric Lefkofsky has been focusing his efforts on Tempus. The business has an important mission and has been working with many medical institutions, research centers, and academic institutions, as well as other organizations. Tempus has the goal of revolutionizing cancer medicine and promoting evidence-based research.

Having has been established only four years ago, Tempus has been ranked among the most prominent health tech startups in the United States of America. Many believe in the company and swear it will bring about a new time in medicine as it mentions and research.

The company does extensive cancer testing. That includes RNA sequencing of tumors, sequencing of the germline DNA of patients, immune system characterization, drug testing, pathology, medical imaging, and many other procedures.

Tempus aims to compile all of the information from cancer patients into one giant database. Tempus has developed a powerful software to compile the information and analyze it digitally. The company aims to find clues for improving cancer treatments and to start creating personalized cancer therapy treatments for patients.

Over the years, Tempus has had some difficulties with extremely expensive procedures, need to develop software that read handwriting from compiled doctors’notes, and so on. The business is working using donations made by investors and other people to achieve their goal.

One of the leading believes that drive the company and Mr. Eric Lefkofsky is that there is more to discover and the next discovery might just be the game-changer everyone needs.

To Know More Click Here

Cancer Treatment Centers Of America Creating New Jobs For Healthcare Professionals

In 1988, Richard J Stephenson, a finance entrepreneur, founded the Cancer Treatment Centers of America after experiencing a death in the family due to the illness. The organization was working out of 1 hospital at the time in Zion, Illinois. After the death of his mother, Stephenson realized that patients with cancer needed more specialized and personalized care in terms of cancer treatment. He opened his first center in the Midwestern Regional Medical Center, and later created 4 more centers across the United States. The hospitals are highly accredited and have received numerous awards including the Magnet Award, which is given to hospitals in recognition of great care.

To ensure proper patient care, the hiring staff for CTCA is always on the look out for burgeoning talent and list openings for jobs daily on their website. New medical grad students may want to look to this company for experience in that they provide a paid internship with pay ranging from 12 to 15 dollars per hour. Currently, there is a position available for internship for the summer in the field of marketing. The internship will be based in Tulsa, OK, and is for colleges students who are getting degree in marketing, journalism, or communication. Other jobs available on their website include a Registered Nurse position, Medical Scribe, and Infusion specialist to name a few.

There have been many positive reviews about the company’s benefits on various job websites, like the Glassdoor. According to the website, CTCA offers it’s employees 401K compensation, healthcare plan benefits, paid time off, a plan that promotes fitness.

This organization is highly prestigious and is of high repute within the Healthcare industry. With that being said, the idea is to get an interview with a CTCA hospital, and attain the job. CTCA has 5 hospitals spread across the US, and offers competitive benefits and salaries for prospective employees.

To Learn More Click Here

Curing Cancer: Eric Lefkofsky’s Mission

Born on September 2nd, 1969, Eric Paul Lefkofksky is the CEO and co-founder of Tempus. Eric is also a co-founder and chairman of Group On, Innerworkings, Mediaocean, Echo Global Logistics, Uptake and Light bank. His entrepreneurial, ambitious journey began at the University of Michigan where he began by selling carpets. He graduated with a degree in law.

Eric Lefkofsky is also interested in the well-being of his community. This inspiration has led him and his wife Elizabeth into starting a private charitable organization, Lefkofsky Family Foundation. This foundation drives initiatives for enhancing the lives of those in the societies where the foundation is based. Eric is also a trustee of Lurie Children’s Hospital in Chicago, and the Art Institute of Chicago among other organizations.

Tempus, which was co-founded by Eric Lefkofsky is a technology firm that is assembling the largest consortium of clinical and molecular data with an operating system that will avail and make this information useful. Tempus’ primary goal is to ensure that current patients can gain from others who were before them. This is made possible by Tempus providing doctors with an interactive, analytical and machine learning platform that enables them to offer personalized care to cancer patients.

Recent studies and surveys have shown that there has been an increase in the cost of healthcare. This can be attributed to the fact that most people and health centers are inclined to wanting and providing personalized care. It is also clear that other factors include population, growth and age. Various diseases become a factor in the amount of money that is spent in the healthcare sector alone.

A lot of patients recently have been diagnosed with the different types of cancer. This has led to many inventions aimed explicitly at treating, curing and curbing cancer-related deaths. It is essential to know and note that money is not the push for innovations in the care for cancer patients. The intention is to provide personalised care for patients, treat and prolong lives. Of great importance to is that the data that these innovations record will tremendously help to further the research.

More Information Click Here

Copyright © 2018. Powered by WordPress & Romangie Theme.